Echo Street Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,282
| Closed | -$257K | – | 452 |
|
|
2023
Q1 | $257K | Buy |
+1,282
| New | +$257K | ﹤0.01% | 411 |
|
|
2022
Q2 | – | Sell |
-2,101
| Closed | -$343K | – | 554 |
|
|
2022
Q1 | $343K | Sell |
2,101
-1,830
| -47% | -$299K | ﹤0.01% | 484 |
|
|
2021
Q4 | $667K | Buy |
3,931
+2,111
| +116% | +$358K | ﹤0.01% | 347 |
|
|
2021
Q3 | $344K | Buy |
+1,820
| New | +$344K | ﹤0.01% | 498 |
|
|
2021
Q2 | – | Sell |
-3,019
| Closed | -$426K | – | 582 |
|
|
2021
Q1 | $426K | Buy |
3,019
+1,033
| +52% | +$146K | ﹤0.01% | 338 |
|
|
2020
Q4 | $258K | Buy |
+1,986
| New | +$258K | ﹤0.01% | 335 |
|